A cancer precision medicine platform for multiple simultaneous genomic assays from metastatic biopsies (bx) in ER+ metastatic breast cancer.

Nikhil Wagle,Karla Helvie,M Lloyd,Lori Marini,Adrienne G. Waks,Ofir Cohen,Coyin Oh,Carrie Sougnez,Nelly Oliver,Qaren Quartey,Asaf Rotem,Parin Shah,Neal I. Lindeman,Ian E. Krop,Levi A. Garraway,Eric P. Winer,Nan Lin

A cancer precision medicine platform for multiple simultaneous genomic assays from metastatic biopsies (bx) in ER+ metastatic breast cancer.

2016

Nikhil Wagle
Karla Helvie
M Lloyd
Lori Marini
Adrienne G. Waks
Ofir Cohen
Coyin Oh
Carrie Sougnez
Nelly Oliver
Qaren Quartey
Asaf Rotem
Parin Shah
Neal I. Lindeman
Ian E. Krop
Levi A. Garraway
Eric P. Winer
Nan Lin

11513Background: The ability to perform multiple genomic tests on metastatic (met) bx may enable cancer research and precision medicine. Questions remain about feasibility of obtaining multiple met...

Keywords:

Precision medicine
Cancer
Pathology
Metastatic breast cancer
Medicine
Oncology
Internal medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations